Drugmakers of Ozempic Face Claims of Failed Side Effects Warning in Multidistrict Litigation Case
Judge Karen Martson has been appointed to oversee a massive, multi-district lawsuit, against Novo Nordisk and Eli Lilly, Both drugmakers of GLP-1 class medications. Their popular diabetes and obesity medications include Ozempic, Wegovy, Mounjaro, Trulicity and Zepbound.